Vitamin B-Complexobservational1998

Identification of four novel mutations in severe methylenetetrahydrofolate reductase deficiency.

European journal of human genetics : EJHG

confidence

Key findings

Identified four novel MTHFR mutations (two missense, two nonsense) and a splice variant in severe MTHFR deficiency; no clinical/biological endpoints reported.

View source on PubMed (PMID 9781030) ↗

Sample size
4 families
Population
Four unrelated families from Turkish/Greek ancestry with severe methylenetetrahydrofolate reductase (MTHFR) deficiency
Dosing
not_reported
Duration
not_reported
Route
not_reported
Drug class
water-soluble vitamin
Full abstract

Severe methylenetetrahydrofolate reductase (MTHFR) deficiency is an inborn error of folate metabolism, and is inherited as an autosomal recessive trait. MTHFR is a key enzyme in folate-dependent remethylation of homocysteine, and reduces 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate. Patients with this severe enzymatic deficiency are biochemically characterised by homocystinuria and hypomethioninaemia, and may suffer from neurological abnormalities, mental retardation and premature vascular disease. Here we report the molecular basis of severe MTHFR deficiency in four unrelated families from Turkish/Greek ancestry. By use of reverse-transcriptase (RT)-PCR, subsequently followed by direct sequencing analysis, we were able to identify four novel mutations in the MTHFR gene: two missense (983A-->G; 1027T-->G) and two nonsense (1084C-->T; 1711C-->T) mutations. Furthermore, a splice variant containing a premature termination codon, was observed in one patient, probably as a secondary effect of the 1027T-->G missense mutation. The ongoing identification and characterisation of mutations in the MTHFR gene will provide further insight into the heterogeneity of the clinical phenotype in severe MTHFR deficiency.

Research information, not medical advice. StudyKit summarizes published studies to help you understand your protocol. It does not diagnose, treat, or replace a clinician. Talk to a qualified provider before changing anything you take.